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Abstract
Background: The predicted increase in incidence of oral cavity cancer (OCC) coupled with high mortality and poor prognosis –
particularly when diagnosed at a late/advanced stage – highlights the need for prevention and early detection/screening to reverse
these trends. Dental healthcare professionals in primary care settings have a pivotal role in this effort.
Aim: The aim of this protocol is to detail the process for assessing the evidence for the best practice and methods of early
detection/screening for OCC in primary care dental settings by undertaking a systematic review of global clinical guidelines and
published systematic reviews.
Method: Searches for clinical guidelines and systematic reviews will be conducted in the following databases: Cochrane library,
Medical Literature Analysis and Retrieval System Online (Ovid), Excerpta Medical dataBASE, PubMed, Turning Research into
Practice, SCOPUS and Web of Science Core Collection. Our search will extend to include Google Scholar and international
professional organizations/associations websites. In addition, we will handsearch the bibliographies and undertake citation
searches of the selected papers. Quality appraisal will be undertaken using the Appraisal of Guidelines for Research and Evaluation
version II instrument for the clinical guidelines and both A MeaSurement Tool to Assess Systematic Reviews and Risk of Bias in
Systematic Reviews tools for the systematic reviews. A narrative synthesis approach will be used to assess the evidence of
extracted data, primarily taking account of quality appraisal and recency of publication.
Discussion: The synthesis of evidence will determine best practice for OCC early detection/screening by primary care dental
healthcare professionals and will evaluate the relationship between clinical guidelines and the evidence base available from sys-
tematic reviews in this area.
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Background
Incidence and mortality
Oral cavity (mouth) cancers (OCC) are defined by the World
Health Organization International Classification of Diseases
and Related Health Problems (ICD-10 edition) codes1 to
include cancers of the inner surface of the lips (C00.3–C00.9,
excluding external surface), other and unspecified parts of
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tongue (C02, excluding base of tongue C01), the gum (C03),
floor of mouth (C04), palate (C05) and other and unspecified
parts of mouth (C06). Cancers of the salivary glands and can-
cers of the oropharynx (throat) are excluded from the definition
and beyond the remit of this review.
Globally, there were an estimated 300,373 new cases of
OCC diagnosed and 145,353 deaths recorded in 2012.2 Inci-
dence rates vary worldwide, and while they are consistently
higher among men, there is a general trend for increasing inci-
dence of OCC among women with relatively stable or only
marginal increases among men.3 In England, a population-
based cancer registry analysis found a 77% increase in OCC
between 1955 and 2011 and projected a further increase of 3%
per year to 2025 in both sexes.4 OCC is recognized as a devas-
tating disease with substantial impact for individuals, families,
healthcare providers and wider society.5 The predicted increase
in incidence, coupled with high mortality and poor prognosis of
OCC – particularly when diagnosed at late/advanced stage –
highlights the need for prevention and early detection/screen-
ing to attempt to reverse these trends.
Risk factors
The major recognized behavioural risk factors for OCC include
smoking, alcohol consumption and diets low in fresh fruit and
vegetables,6 while sociodeomographic factors including age
(older adults), gender (male) and low socioeconomic status are
also considered substantially important.7 Evidence is also
emerging on the role of genetic variants6 and poor oral health
and dental care.8 Oral human papillomavirus infection seems to
have a limited role in OCC, being mainly implicated in the
aetiology of the distinct disease of oropharyngeal (throat)
cancer.9,10
Survival rate and early detection
There has been limited improvement in the 5-year survival rate
from OCC in the last few decades.11,12 A recent meta-analysis
confirmed that delay from first symptom to referral for diag-
nosis is a risk factor for advanced stage presentation and sub-
sequently poorer mortality of oral cancer.13 Therefore,
conversely, early detection/screening, including symptom rec-
ognition and clinical examination of the oral mucosa together
with assessment of risk factors, can potentially improve prog-
nosis. This has been evidenced by a large randomized control
trial in Kerala, India, which demonstrated that oral visual
screening in community settings by healthcare support workers
can reduce mortality associated with OCC in high-risk (users of
tobacco and alcohol) individuals, albeit in a high-incidence
country.14
Screening/early detection
Screening is the process of detecting disease early via under-
taking a screening test. Such a test is not in itself diagnostic but
indicates increased risk of developing the disease or identifies
the presence of early stages of disease progression (with or
without obvious signs or symptoms). A positive screening test
finding indicates the need for referral for definitive diagnostic
tests and early interventions.
In countries with universal (population coverage) primary
care dental services, dental healthcare professionals have a role
in providing ‘opportunistic’ screening/early detection via
visual conventional oral examinations as part of routine dental
services. This is often included in recommendations from den-
tal organizations or societies (e.g. Scottish Intercollegiate
Guidelines Network (SIGN))15 and is an expectation of dental
regulatory bodies (e.g. General Dental Council in the United
Kingdom).16 These recommendations are communicated
through clinical guidelines for dental healthcare professionals
working in primary care and have been developed by a range of
different health and professional organizations and agencies
worldwide (e.g. US Preventive Service Task Force,17 Ameri-
can Cancer Society18 and SIGN).16 However, our initial search
of the literature and clinical guidelines indicated a lack of
consensus between the clinical guidelines and insufficient evi-
dence in the literature on providing direction to dental health-
care professionals on the details of the early detection/
screening process. This includes the nature/description of
assessment (conventional clinical oral examination, frequency
of assessment/recall), the use of the adjunct tools (e.g. vital
staining, light-based detection, biomarkers and brush biopsy),
setting and whether the approach should be a targeted (i.e. to
high-risk patients stratified/determined by sociodeomographic/
behavioural risk factors) versus a population (i.e. universal to
all patients) approach. In addition, the extent to which the
guidelines have included the highest quality evidence, and
indeed have adopted a robust literature search, and quality
appraisal is uncertain. Therefore, there is a need to assess the
relevant clinical guidelines and systematic reviews in this field
using a systematic approach to provide clarity for primary care
dental healthcare teams on the best early detection/screening
practice for OCC and potentially malignant disorders.
Aims/objectives
The aim of this protocol is to detail the process for assessing the
evidence for the best methods for early detection/screening for
OCC (and by implication potentially malignant disorders) in
the primary care dental setting by undertaking a systematic
review of clinical guidelines and systematic reviews.
The dental healthcare professionals in this systematic
review include dentists, dental therapists and dental hygienists
working in primary care community healthcare settings.
The Population, Intervention, Comparator, Outcome and
Setting model19 was used to develop the following review
question:
What clinical examination methods for early detection/
screening of OCC are considered best practice for dental
healthcare professionals when assessing patients attending pri-
mary care dental settings, including description of the clinical
examination; frequency of the assessment; use of adjunct
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methods and whether the approach should be population,
opportunistic or targeted based on risk factors?
Objectives
 To systematically search for evidence including sys-
tematic reviews and clinical guidelines in relation to
early detection/screening for OCC in primary care den-
tal settings.
 To appraise the quality of the evidence using assessing
the methodological quality of systematic reviews
(AMSTAR) and risk of bias in systematic reviews
(ROBIS) tools for the systematic reviews and the
Appraisal of Guidelines for Research and Evaluation
version 2 (AGREE II) instrument for the clinical
guidelines.
 To describe the clinical examination/assessment pro-
cess, frequency of the assessment, use of the adjunct
methods, the applicability to dental setting and the
approach (opportunistic – universally to all patients; or
targeted/focused/different (e.g. more intensive) based on
patient’s risk factors).
 To synthesize the evidence of the extracted data from the
systematic reviews and clinical guidelines primarily tak-
ing account of the quality appraisal and recency of pub-
lication. This will lead to the development of (based on
the best available evidence) recommendations for OCC
early detection/screening processes for primary dental
healthcare professionals.
Methods
We referred to the Preferred Reporting Items for Systematic
review andMeta-Analysis – Protocols (PRISMA-P) 2015 state-
ment, other published protocols20 and systematic reviews21,22
to develop this protocol. The PRISMA-P 2015 check list is
included in Online Appendix 1.
Eligibility criteria
Types of study. Our overview study will include evidence from
systematic reviews and clinical guidelines in relation to early
detection/screening for OCC in primary care dental settings.
Both clinical guidelines and systematic reviews are likely to
include specific recommendations and evidence on OCC early
detection/screening for dental healthcare professionals in pri-
mary care settings. Our search will include peer-reviewed and
grey literature and will not be restricted to any language. The
systematic reviews will be searched from 1946 to current date
and the clinical guidelines will be sought from 2000. We will
exclude case studies/reports, published abstract only and sys-
tematic review protocols.
Types of participants. The population group for this overview
will be the adult population (including high-risk group individ-
uals) who attend primary care dental settings.
Types of interventions. This will include early detection/screen-
ing interventions for detecting OCC by dental healthcare pro-
fessionals in the primary care dental settings. These
interventions will include conventional clinical oral examina-
tions along with other adjunct methods (such as vital rinsing/
staining, light-based detection, blood and saliva biomarker
analysis and brush biopsy).
This study will intend to achieve the following outcomes:
 Evidence for effectiveness of interventions (e.g. does
early detection/screening decrease the incidence rates
of OCC; does early detection/screening improve the
stage of diagnosis and/or improve mortality rates and
what could be the harms of the screening or is it cost
effective?).
 Description of an evidence-based preventive interven-
tion (i.e. description of the clinical oral examination;
frequency of the assessment; use of adjunct methods and
whether the approach should be population, opportunis-
tic or targeted based on risk factors).
Types of setting. This study will focus on applicability to primary
care (community) dental settings.
Information sources
A systematic review for clinical guidelines and systematic
reviews in the worldwide literature will be performed with the
medical subject librarian (HW-A) in the following databases:
Cochrane Library from 1966 to present, Medical Literature
Analysis and Retrieval System Online (MEDLINE) from
1946 to present, Excerpta Medical dataBASE (EMBASE) from
1947 to present, Web of Science Core Collection: Citation
Indexes from 1900 to present, PubMed (a free search engine
accessing primarily the MEDLINE database of references and
abstracts on life sciences and biomedical topics) from 1946 to
present, SCOPUS (a bibliographic database containing
abstracts and citations for academic journal articles) from
1966 to present and Turning Research into Practice (TRIP)
from 2000 to present.
Professional organizations/associations websites from
around the world will be searched for additional global clinical
guidelines in relation to OCC early detection. A list of profes-
sional organizations/associations is included in Online Appen-
dix 2. Despite the limitations in searching on Google in relation
to language, geographical biases and lack of replicability, a list
of target phrases will be run in Google searches to discover
grey literature in the form of web-published guidelines from
official bodies. Online Appendix 3 includes list of phrases used
for Google search.
The reference lists of the selected papers will be hand-
searched for additional studies. In addition, we will conduct
citation searches in Google Scholar and Web of Science of the
selected papers to identify further systematic reviews and clin-
ical guidelines.
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Search strategy
A search strategy will be developed with the medical librarian
and a clinical expert in the area of OCC (JG). The following
terms will be used to search in different databases: ‘cancer,
neoplasm/oral, mouth/head, neck, buccal, lips/tongue/assess,
screen, inspect and exam’. The terms will be followed by
appropriate truncation symbols for example (* or $). For fur-
ther refinement Boolean operators such as (AND/OR? proxim-
ity) will be used. The search will be limited to titles/abstracts
rather than full bibliographic records.
The search results in MEDLINE and EMBASE will be lim-
ited to systematic reviews, using the SIGN search filter, or
clinical guidelines, using Texas School of Public Health search
filter.23 These search filters are pretested strategies that identify
the higher quality evidence which are indexed in the major
medical databases. Online Appendix 4 includes a sample of
search strategy in MEDLINE.
Data management
All the search results including bibliographies, citation and
references will be managed through a reference manager ‘End-
note’. The collected records (systematic reviews and clinical
guidelines) will be evaluated independently by two investiga-
tors from the research team (NMB, LMDM, JG, HW-A and
DIC). The evaluation will include reviewing titles, abstracts
and full text of articles. Duplicate records will be removed. A
PRISMA four-phase flow diagram will be designed to indicate
the search process. The diagram will map out information
about the number of records identified in the literature searches
based on inclusion criteria, number of studies included and
excluded and the reasons for exclusion. The final selected sys-
tematic reviews and clinical guidelines will be assessed for
quality and risk of bias. Any discrepancies between the inves-
tigators will be resolved by consensus. This stage will be
adapted from Cochrane Collaboration.24
Data extraction
The Cochrane Collaboration data collection form will be
adopted, modified and pilot tested to meet study specified
requirements.24 The piloted data extraction form will be used
independently by two investigators from our review team. The
following information will be extracted from the included sys-
tematic reviews and clinical guidelines: authors/organization
(e.g. Cochrane, ADA), date of publication, funding source(s),
number/type of studies included, type of synthesis, population
(e.g. age group, gender), time period, interventions, compari-
son (vs. no screening, or comparison in high-risk group), out-
comes, main results and conclusions – including
recommendations which will include the level of evidence used
within the systematic review and clinical guidelines. A sample
data extraction form for the systematic review is included in
Online Appendix 5. A similar form will be used to extract the
data from the clinical guidelines (Online Appendix 6). Any
missing information from the reports will be recorded as ‘not
described’ in the data extraction forms. Discrepancies will be
resolved through discussion by the review team.
Quality assessment and risk of bias
Systematic reviews. The methodological quality and the risk of
bias of the included systematic reviews will be assessed by two
reviewer using two different tools: AMSTAR25 and ROBIS
tool.26 The AMSTAR tool is a valid and reliable tool.27 It
consists of 11 items assessing quality of the key stages of
systematic reviews.25 The recently developed ROBIS26 tool
is completed in three phases to (1) assess relevance (optional);,
(2) identify concerns across four domains of systematic
reviews – study eligibility criteria, identification and selection
of studies, data collection and study appraisal and synthesis and
findings – with the review process and (3) judge risk of bias.
The outputs of the AMSTAR and ROBIS tools will be com-
pared, and the items/domain which focused on quality apprai-
sal will be prioritized in data synthesis.
Clinical guidelines. The quality of the clinical guidelines will be
assessed by two reviewers using the AGREE II instrument.28
This tool consists of 23 key items organized within six domains
followed by two global rating items (‘overall assessment’).
Each capturing a unique dimension of quality, followed by
an overall quality assessment score.
Data synthesis
Initially, we will establish two separate lists of clinical guide-
lines and systematic reviews as independent categories. Each
category will be synthesized separately according to the Centre
for Reviews and Dissemination guidance for undertaking sys-
tematic reviews.29 We will focus the synthesis on the following
themes: description of the clinical examination; frequency of
the assessment; use of adjunct methods and whether the
approach should be population, opportunistic or targeted based
on risk factors. Analysis between and within the themes will
follow the thematic description, along with assessing the
strength of the evidence and recommendations.30,31 In addition
to the thematic structure, the quality of the systematic reviews/
clinical guideline along with time/recency of publication will
take primacy in the synthesis of recommendations.
Overview of clinical guidelines and systematic reviews
Following the data synthesis of the two categories, we will be
able to evaluate the relationship between clinical guidelines
and the evidence base available from systematic reviews (i.e.
to assess if the clinical guidelines reflect the evidence base
from the systematic reviews or if there are gaps in the
evidence).
We are certain that this innovative method, also being
implemented in a similar study,20 will add to the existing body
of knowledge and provide dental health professionals with the
best evidence-based method for early detection/screening for
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OCC and potentially malignant disorders in the primary health-
care settings. The synthesized evidence will be used to make
recommendations for OCC early detection/screening processes
for the dental healthcare professionals.
This protocol is the first step in undertaking a systematic
review of the best evidence and guidelines in relation to the
early detection of oral cancer. It sets out the methods for under-
taking a systematically search, quality appraisal and synthesis
of the evidence from published systematic reviews and clinical
guidelines to inform dental healthcare professionals in relation
to the early detection/screening for OCC. It will assist in the
process of identifying potential gaps in the extent of systematic
reviews and the clinical guidelines – including how well clin-
ical guidelines reflect the systematic review literature. The end
point of this systematic review aims to support dental profes-
sionals, researchers, policymakers and guideline developers by
providing high-quality evidence on interventions that will
improve clinical practice and patient care. The findings will
inform the development of an early detection/screening oral
cancer intervention.
Dissemination of findings
We will report the findings of the review using the PRISMA
statement.32 We will also share the findings in a peer review
journal, communicate the findings with professional bodies and
policymakers and participate in scientific meetings and
national and international conferences. The findings will also
be submitted as part of a PhD degree.
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Translational value
This protocol is the first step in undertaking a systema-
tic review of the best evidence and guidelines in rela-
tion to the early detection of oral cancer. It sets out the
methods for undertaking a systematic search, quality
appraisal and synthesis of the evidence from published
systematic reviews and clinical guidelines to inform
dental healthcare professionals in relation to the early
detection/screening for oral cavity cancer (OCC). It
will assist in the process of identifying potential gaps
in the extent of systematic reviews and in the clinical
guidelines – including how well clinical guidelines
reflect the systematic review literature. The end point
of this systematic overview aims to support dental pro-
fessionals, researchers, policymakers and guideline
developers by providing high-quality evidence on inter-
ventions that will improve clinical practice and patient
care. The findings will inform the development of an
early detection/screening oral cancer intervention.
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